Senior Team

Zheng Wei, Ph.D.

Dr. Zheng has served as CEO and a member of our board of directors since he co-founded the company in 2012. He has over 25 years of biopharmaceutical industry experience in the autoimmune disease and inflammation therapeutic areas. Prior to co-founding Connect, Dr. Zheng was Director of Immunology at Arena Pharmaceuticals where he oversaw its … Read more

Wubin (Bill) Pan, Ph.D., MBA

Dr. Pan is a co-founder of Connect and has served as President and Chairman of the Board of Directors since May 2012. He has over 25 years of experience in biopharmaceutical R&D, including 10 years in Europe and North America. Prior to co-founding Connect, Dr. Pan co-founded and led Crown Bioscience Inc., a U.S. venture-backed … Read more

Steven Chan

Steven Chan joined Connect as CFO in November 2021.  He brings 25+ years of financial experience leading life science, technology, financial services, and manufacturing companies.  Most recently, he was CFO at Delphon Industries, an advanced materials manufacturer based in the Bay Area.  Prior to that, he built out the finance teams at Arcus Biosciences and … Read more

Jiang Bian, JD

Mr. Bian has served as General Counsel and Chief Compliance Officer since August 2021. He joined Connect Biopharma from Guardant Health, Inc., a publicly traded precision oncology diagnostics company, based in Redwood City, California, where he served as Senior Counsel.

Lei Sun, Ph.D.

Dr. Sun has over 20 years of experience in pharmaceutical development of biologics focused on process development, CMC, and manufacturing operations. Prior to joining Connect, Dr. Sun served as Chief Technology Officer and Vice President of Manufacturing at Autekbio Diagnostics. Prior to serving at Autekbio Diagnostics, Dr. Sun supported drug development at PERCIVIA, UCB Pharma, … Read more

Raúl Collazo, Ph.D.

Dr. Raúl Collazo joined the Company in November 2021 to lead the Medical Affairs function.  He has over 20 years of Medical Affairs experience in small biotech and large pharmaceutical environments.  Additionally, he brings extensive expertise advising pre-commercial life science companies on medical/scientific affairs, compliance, operations, and corporate strategy through his own consulting firm.  Prior … Read more

Qingjian (QJ) Wang, Ph.D.

Dr. QJ Wang joined Connect in July 2021 to lead the nonclinical programs. He is an experienced pharmacology and toxicology professional with about 30 years of experience working in various capacities in pre/nonclinical drug R&D. Prior to joining the company, he was a Senior Director of R&D at FibroGen, San Francisco. QJ is a key … Read more

Mark McDade

Mr. McDade is Co-founder and Managing Partner of the Qiming US Healthcare Fund, a venture capital firm based in Seattle and formed in January 2017. Prior to Qiming, from April 2008 until his retirement in October 2016, Mr. McDade was EVP and Chief Operating Officer at UCB S.A., a Belgian biopharmaceutical company. From 2002 to … Read more